Losing weight too quickly without adequate protein intake and appropriate resistance exercise can lead to loss of lean muscle mass
Current multi-society guidance updated in 2024 suggests many patients can continue their GLP-1 medication around surgery using a risk-based plan, rather than an automatic stop
Skipping Cycling Protocols The Problem: Continuous daily use without planned off-periods, assuming "more is better." Why It Matters: Prolonged use without breaks may lead to receptor desensitization, reduced effectiveness, and potential unknown long-term effects
Sexually transmitted diseases treatment guidelines, 2015
The search included terms such as small molecule GLP-1 receptor agonists, oral GLP-1 receptor agonists, Danuglipron, Orforglipron, and Aleniglipron. Additionally, information on ongoing clinical trials involving small molecule GLP-1 receptor agonists was retrieved from the ClinicalTrials.gov database using the same keywords